Toward deep learning replacement of gadolinium in neuro-oncology: A review of contrast-enhanced synthetic MRI
{{output}}
Gadolinium-based contrast agents (GBCAs) have become a crucial part of MRI acquisitions in neuro-oncology for the detection, characterization and monitoring of brain tumors. However, contrast-enhanced (CE) acquisitions not only raise safety concerns, but also ... ...
